| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| HLA-A*0201 & B2M & PSMA (MMNDQLMFL) | Biotinylated Human HLA-A*02:01&B2M&PSMA (MMNDQLMFL) Complex Protein (Monomer, MALS verified) |  Human | HEK293 | MALSSDS-PAGE | $125.00 25ug |   |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Tarperprumig | ALXN-1820 | Phase 2 Clinical | Alexion Pharmaceuticals Inc | Anemia, Sickle Cell | Details |
| NM-5072 | NM5072; NM-5072 | Phase 1 Clinical | NovelMed Therapeutics Inc | Hemoglobinuria, Paroxysmal | Details |
